Ligustilide alleviates sepsis-associated acute kidney injury by activating Nrf2/HO-1 and PI3K/Akt signaling pathways
The International Journal of Biochemistry & Cell Biology · 2026-08 · 197-198 · 106945
DOI: 10.1016/j.biocel.2026.106945 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2026-08. Verfasst von Min Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The First Affiliated Hospital of Bengbu Medical University, Bengbu 230000, China. Hauptthemen laut MEDLINE: 4-Butyrolactone, NF-E2-Related Factor 2, Sepsis, Acute Kidney Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Themen: Sepsis
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, The First Affiliated Hospital of Bengbu Medical University, Bengbu 230000, China.
- Department of Emergency Medicine, The First Affiliated Hospital of Bengbu Medical University, Bengbu 230000, China. Electronic address: xubodoctor@hotmail.com.
- Department of Emergency Medicine, The First Affiliated Hospital of Bengbu Medical University, Bengbu 230000, China.
Zitieren
APA
Huang, M., Xu, B., Qi, H., Xu, H., & Cai, L. (2026). Ligustilide alleviates sepsis-associated acute kidney injury by activating Nrf2/HO-1 and PI3K/Akt signaling pathways. The International Journal of Biochemistry & Cell Biology, 197-198, 106945. https://doi.org/10.1016/j.biocel.2026.106945
Vancouver
Huang M, Xu B, Qi H, Xu H, Cai L. Ligustilide alleviates sepsis-associated acute kidney injury by activating Nrf2/HO-1 and PI3K/Akt signaling pathways. The International Journal of Biochemistry & Cell Biology. 2026;197-198:106945. doi:10.1016/j.biocel.2026.106945
BibTeX
@article{Huang2026,
author = {Huang, Min and Xu, Bo and Qi, Hang and Xu, Hongzhou and Cai, Liang},
title = {Ligustilide alleviates sepsis-associated acute kidney injury by activating Nrf2/HO-1 and PI3K/Akt signaling pathways},
journal = {The International Journal of Biochemistry & Cell Biology},
year = {2026},
volume = {197-198},
pages = {106945},
doi = {10.1016/j.biocel.2026.106945}
}
EUVIMED